A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the increasing price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and customer laws, risking penalties, legal action or prison.
Service Reaction and Content Elimination
According to TikTok, the service has removed problematic content and banned associated keywords and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, populated with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at home.
After moments of joining one group, a seller shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and guaranteed delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Product Details and Costs
Within these communities, messages display dark colored packages with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.
